Clinical trial
Genetic Study in Patients With Stage II or Stage III Colon Cancer
NCT00003833 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003833 |
|---|---|
| Title | Genetic Study in Patients With Stage II or Stage III Colon Cancer |
| Official title | The Clinical and Pathological Significance of Allelic Imbalance of 8p in Patients With Colorectal Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH NCIC Clinical Trials Group |
| Status | Completed |
| Study type | Observational |
| Conditions | Colorectal Cancer |
| Intervention type | Genetic |
| Interventions | DNA stability analysis, gene mapping |
| Enrollment | 598 |
| Start date | Feb 1, 1999 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 13, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: